Misuse of verapamil in pre-excited atrial fibrillation

Lancet. 1989 Feb 18;1(8634):367-9. doi: 10.1016/s0140-6736(89)91734-0.

Abstract

Of 18 patients who attended accident and emergency departments with pre-excited atrial fibrillation, 10 were inappropriately treated with intravenous verapamil. The reason for the inappropriate treatment was misdiagnosis of the arrhythmia, although diagnostic electrocardiograms were available for all patients: in only 3 of the 18 patients was the correct diagnosis made before intervention. Misdiagnosis occurred because of failure to consider pre-excitation as a possible diagnosis, rather than bias towards a single alternative arrhythmia. The use of intravenous verapamil was associated with deterioration in the clinical condition of 6 patients and continued arrhythmia in all 10.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / physiopathology
  • Diagnostic Errors
  • Emergencies
  • Female
  • Heart Ventricles
  • Humans
  • Injections, Intravenous
  • Medication Errors
  • Middle Aged
  • Retrospective Studies
  • Tachycardia / diagnosis
  • Tachycardia / drug therapy
  • Tachycardia / physiopathology
  • Verapamil / administration & dosage
  • Verapamil / adverse effects*
  • Wolff-Parkinson-White Syndrome / complications
  • Wolff-Parkinson-White Syndrome / drug therapy*
  • Wolff-Parkinson-White Syndrome / physiopathology

Substances

  • Verapamil